Information for Patients and Caregivers

This site contains information on skin, mouth and hair changes (known as adverse reactions) that can sometimes occur with a particular type of cancer drug, known as multikinase inhibitors. This section is for patients receiving the following cancer treatments only: Cabometyx®/ Cometriq® (cabozantinib), Caprelsa® (vandetanib), Glivec®/ Gleevec® / Imatinib® (imatinib), Lenvima®/ Kisplyx® (lenvatinib), Nexavar® (sorafenib), Rydapt® (midostaurin), Sprycel® (dasatinib), Stivarga® (regorafenib), Sutent® (sunitinib) and Votrient® (pazopanib). Here, we aim to bring you important information on how you can work with your doctor/nurse to manage skin, mouth and hair adverse reactions to your cancer treatment.